Attached files
file | filename |
---|---|
S-1/A - AMENDMENT NO. 4 TO FORM S-1 - FATE THERAPEUTICS INC | d552384ds1a.htm |
EX-5.1 - EX-5.1 - FATE THERAPEUTICS INC | d552384dex51.htm |
EX-10.25 - EX-10.25 - FATE THERAPEUTICS INC | d552384dex1025.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the captions Risk factorsRisks related to our financial position, Managements discussion and analysis of financial condition and results of operations, and Experts and to the use of our report dated June 17, 2013 (except for paragraph 14 of Note 9, as to which the date is September 12, 2013), in Amendment No. 4 to the Registration Statement (Form S-1 No. 333-190608) and related Prospectus of Fate Therapeutics, Inc. dated on or about September 27, 2013 for the registration of shares of its common stock.
/s/ Ernst & Young
San Diego, California
September 27, 2013